US Department of Labor finds Charleston Walgreens store employed 12-year-old worker in violation of child labor laws | U.S. Department of Labor
US Department of Labor finds Charleston Walgreens store employed 12-year-old worker in violation of child labor laws
Corporate conductSettlementAgainst
The U.S. Department of Justice filed a civil complaint alleging that Walgreens knowingly filled millions of prescriptions that lacked a legitimate medical purpose
Office of Public Affairs | Justice Department Files Nationwide Lawsuit Alleging Walgreens Knowingly Filled Millions of Prescriptions that Lacked a Legitimate Medical Purpose | United States Department of Justice.
The complaint claims that Walgreens dispensed millions of unlawful prescriptions, including opioids, and sought reimbursements from federal health care programs for prescriptions that were improperly filled.
Justice Department Accuses Walgreens Of Violating Drug Laws In Opioid Epidemic, Ignored Red Flags In Opioid Crisis
Walgreens systematically pressured pharmacists to fill prescriptions without taking the time to confirm their validity, according to the complaint.Gene J.
Walgreens Agrees to Pay Up to $350M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services
Walgreens Boots Alliance has agreed to pay $300 million to settle claims that it unlawfully filled millions of invalid prescriptions for opioids and other controlled substances.
The government also alleged that Walgreens submitted the invalid prescriptions to federal health insurance programs, including Medicare for reimbursement, in violation of the federal False Claims Act.
General (HHS-OIG), announced a $300 million settlement with Walgreens Boots Alliance,
Complaint Filed Against Houston Pharmacy and its Owners for Violations of the Controlled Substances Act April 28, 2025 Stamford Nurse Admits Stealing and Tampering with Hydromorphone and Fentanyl Vials April 25, 2025 Walgreens Agrees to Pay Up to $350M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government April 21, 2025 Private Shipping Company to Pay $400,000 to Settle Allegations of Transshipping Fentanyl Precursor Chemicals March 26, 2025
Department of Justice this week filed a lawsuit against Walgreens, alleging the company knowingly filled illegal prescriptions with no medical purpose, including opioids.
Walgreens is accused of filling millions of illegal prescriptions in a violation of the Controlled Substances Act and then trying to get federal reimbursement for the prescriptions through various federal health care programs in violation of the False Claims Act, according to the nationwide lawsuit filed in the U.S. District Court for the Northern District of Illinois.
Walgreens sued by DOJ, alleging it knowingly filled illegal prescriptions, including 'dangerous' opioids | FOX 5 New York
The suit, filed Thursday in Illinois federal court, alleges that between 2012 and the present, Walgreens “knowingly filled millions of prescriptions for controlled substances that lacked a legitimate medical purpose,” according to the DOJ.
“This lawsuit seeks to hold Walgreens accountable for the many years that it failed to meet its obligations when dispensing dangerous opioids and other drugs,” Deputy Assistant Attorney General Brian M.
DOJ accuses Walgreens of ignoring ‘red flags’ and driving opioid crisis with invalid prescriptions | The Independent
Office of Public Affairs | Justice Department Files Nationwide Lawsuit Alleging Walgreens Knowingly Filled Millions of Prescriptions that Lacked a Legitimate Medical Purpose | United States Department of Justice
District Court for the Northern District of Illinois, the Justice Department alleges that Walgreens Boots Alliance, Walgreen Co. and various subsidiaries (collectively, Walgreens) dispensed millions of unlawful prescriptions in violation of the Controlled Substances Act (CSA) and then sought reimbursement for many of these prescriptions from various federal health care programs in violation the False Claims Act (FCA).
“Importantly, Walgreens’s agreements with the DEA and HHS-OIG provide swift relief in the form of monitoring and claims review that will improve Walgreens’s practices immediately,” said U.S. Attorney Andrew S. Boutros for the Northern District of Illinois.
Office of Public Affairs | Walgreens Agrees to Pay Up to $350M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government | United States Department of Justice
District Court for the Northern District of Illinois, alleges that from approximately August 2012 through March 1, 2023, Walgreens, one of the nation’s largest pharmacy chains, knowingly filled millions of unlawful controlled substance prescriptions.
“This settlement holds Walgreens accountable for failing to comply with its critical responsibility to prevent the diversion of opioids and other controlled substances,” said U.S. Attorney John J. Durham for the Eastern District of New York.
District of Maryland | Justice Department Files Nationwide Lawsuit Alleging Walgreens Knowingly Filled Millions of Prescriptions that Lacked a Legitimate Medical Purpose | United States Department of Justice
Middle District of Florida | Walgreens Agrees to Pay Up to $350M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government | United States Department of Justice
“This settlement resolves allegations that, for years, Walgreens failed to meet its obligations when dispensing dangerous opioids and other drugs,” said Deputy Assistant Attorney General Michael Granston of the Justice Department’s Civil Division.
District Court for the Northern District of Illinois, alleges that from approximately August 2012 through March 1, 2023, Walgreens, one of the nation’s largest pharmacy chains, knowingly filled millions of unlawful controlled substance prescriptions.
“This settlement holds Walgreens accountable for failing to comply with its critical responsibility to prevent the diversion of opioids and other controlled substances,” said U.S. Attorney John J. Durham for the Eastern District of New York.
“This lawsuit seeks to hold Walgreens accountable for the many years that it failed to meet its obligations when dispensing dangerous opioids and other drugs,” said Principal Deputy Assistant Attorney General Brian Boynton, head of the DOJ’s Civil Division.
DOJ sues Walgreens, alleging it 'knowingly' filled millions of prescriptions that lacked legit medical purposes
Nashville- Tennessee Attorney General Jonathan Skrmetti announced today that he has finalized agreements with CVS and Walgreens, bringing the national opioid crisis settlement total to more than $50 billion. Under today’s agreements, CVS will pay $5 billion, and Walgreens will pay $5.7 billion, totaling $10.7 billion. Should all incentives be met, Tennessee is expected to receive more than $127 million from CVS and more than $138 million from Walgreens, totaling a combined $265 million.
Under today’s agreements, CVS will pay $5 billion, and Walgreens will pay $5.7 billion, totaling $10.7 billion.
Should all incentives be met, Tennessee is expected to receive more than $127 million from CVS and more than $138 million from Walgreens, totaling a combined $265 million.
Nashville- Tennessee Attorney General Jonathan Skrmetti announced today that he has finalized agreements with CVS and Walgreens, bringing the national opioid crisis settlement total to more than $50 billion.
The government's January lawsuit alleged Walgreens ignored "red flags" that prescriptions were illegal and filled them anyway, violating the Controlled Substances Act.
Walgreens WBA.O has agreed to pay $300 million to settle U.S. prosecutors' allegations that it illegally filled millions of invalid prescriptions for opioids and other controlled substances, the U.S. Justice Department said on Monday.
Corporate conductConfirmedAgainst
Walgreens paid for unnecessary insulin
Walgreens paid federal healthcare programs millions for insulin beneficiaries didn't need, leading to significant medication waste.
As a result, federal healthcare programs paid WALGREENS millions of dollars for insulin that many beneficiaries did not actually need, and substantial quantities of valuable medication were wasted.
As a result, federal healthcare programs paid WALGREENS millions of dollars for insulin that many beneficiaries did not actually need, and substantial quantities of valuable medication were wasted.
Corporate conductConfirmedAgainst
Walgreens dispenses Mifepristone where legal
Walgreens says it will dispense Mifepristone in any jurisdiction where it is legally permissible.
"We want to be very clear about what our position has always been: Walgreens plans to dispense Mifepristone in any jurisdiction where it is legally permissible to do so," a statement from Walgreens said, reversing its initial messaging that it would sell Mifepristone where it is "legal and operationally feasible."
Walgreens Pays $205,000 in EEOC Pregnancy and Disability Discrimination Lawsuit
NEW ORLEANS – Pharmacy and retailer Walgreens Co. has agreed to pay $205,000 and provide other relief to settle a pregnancy discrimination lawsuit filed by the U.S. Equal Employment Opportunity Commission (EEOC), the federal agency announced today.
Now, Walgreens has agreed to pay $205,000 to settle the lawsuit accusing the company of pregnancy and disability discrimination, the EEOC said in a March 15 news release.
The woman wasn’t granted emergency leave after her doctor advised her to seek care even though “Walgreens ordinarily permits employees to leave if they are experiencing an emergency,” the lawsuit says.
Now, Walgreens has agreed to pay $205,000 to settle the lawsuit accusing the company of pregnancy and disability discrimination, the EEOC said in a March 15 news release. The company is required to pay the woman the full settlement amount, court documents show.
LGBTQ+ policiesConfirmedYou decide
Walgreens backs Florida politicians for 'don't say gay' bill
Walgreens donated to Florida politicians supporting the 'don't say gay' bill.
Companies such as Comcast/NBCUniversal, AT&T, and Walgreens all purport to be supportive of LGBTQ+ people -- but they and other pro-LGBTQ+ businesses have donated to Florida politicians who are backing the state's notorious "don't say gay" bill.
Workplace equityAllegationAgainst
Walgreens is accused of telling pregnant employee she's not a good fit
Walgreens is accused of telling a pregnant woman she was not a good fit for the company and that she had asked for too many accommodations.
The manager told the woman “that (she) was not a good fit for Walgreens now that she was pregnant, and that (she) had asked for too many accommodations,” according to the lawsuit.
Workplace equitySettlementAgainst
Walgreens agreed to share policies at its retail stores in ten cities about how pregnancy discrimination
As part of a two-year consent decree, Walgreens must share policies at its retail stores in ten cities about how pregnancy discrimination and related retaliation is prohibited, the EEOC said.
As part of a two-year consent decree, Walgreens must share policies at its retail stores in ten cities about how pregnancy discrimination and related retaliation is prohibited, the EEOC said.
Corporate conductSettlementAgainst
Walgreens agreed to pay nearly $6 million to settle FTC charges that the company deceptively advertised its 'Wal-Born' supplements
National pharmacy chain Walgreens has agreed to pay nearly $6 million to settle FTC charges that the company deceptively advertised “Wal-Born” – a line of dietary supplements similar to the Airborne cold-and-flu treatment – using the same kind of baseless claims that the supplements could prevent colds, fight germs, and boost the immune system.
According to the FTC’s complaints, Walgreens advertised its Wal-Born supplements online, in newspaper circulars nationwide, and on packaging.
Walgreens sold the supplements under its store name, and touted their similarity to supplements sold by Airborne Health, Inc., which settled FTC deceptive advertising charges in 2008.
Walgreens Will Pay Nearly $6 Million to Settle FTC Deceptive Advertising Charges | Federal Trade Commission
Walgreens Will Pay Nearly $6 Million to Settle FTC Deceptive Advertising Charges
Improvita manufactured store-brand versions of Airborne for various retailers, including Walgreens and Rite Aid, and it marketed its own brand of lozenges and tablets under the name Germ Defense.
The FTC’s agreements with Walgreens and the Improvita officers come after the agency settled similar cases last year alleging that two other pharmacy chains, CVS and Rite Aid, deceptively advertised the same kinds of supplements sold in their stores.
National pharmacy chain Walgreens has agreed to pay nearly $6 million to settle FTC charges that the company deceptively advertised “Wal-Born” – a line of dietary supplements similar to the Airborne cold-and-flu treatment – using the same kind of baseless claims that the supplements could prevent colds, fight germs, and boost the immune system.
Walgreens sold the supplements under its store name, and touted their similarity to supplements sold by Airborne Health, Inc., which settled similar deceptive advertising charges by the FTC in 2008.
FTC Tells Consumers They May Be Due a Refund If They Purchased Walgreens "Wal-Born" Cold and Flu Supplements | Federal Trade Commission
National pharmacy chain Walgreens agreed to pay nearly $6 million in 2010, to settle FTC charges that it deceptively advertised that its “Wal-Born” line could effectively prevent colds, fight germs, and boost the immune system.
According to the FTC’s complaint, Walgreens advertised its Wal-Born supplements online, in newspaper circulars nationwide, and on packaging.
FTC Sends Refund Checks to Consumers Who Bought Walgreens' 'Wal-Born' Dietary Supplements
FTC Sends Refund Checks to Consumers Who Bought Walgreens' 'Wal-Born' Dietary Supplements | Federal Trade Commission
An administrator working for the Federal Trade Commission is mailing 7,979 checks averaging $27.42 each to consumers who bought dietary supplements sold by national pharmacy chain Walgreens under its store-brand “Wal-Born” label.
In 2010, Walgreens settled FTC charges that it deceptively advertised that the supplements could effectively prevent colds, fight germs, and boost the immune system.
Corporate conductConfirmedAgainst
Walgreens submits false claims to Medicare Medicaid
Walgreens is accused of submitting payment claims to Medicare, Medicaid, and other healthcare programs for prescriptions never picked up between 2009 and 2020.
The Justice Department said Walgreens violated the federal False Claims Act between 2009 and 2020 by submitting payment claims to Medicare, Medicaid and other healthcare programs for prescriptions it processed but which were never picked up.